A Hong Kong AI-for-drug-discovery startup building open biomolecular structure prediction and binding affinity models for therapeutic design.
IntelliGen AI
Released July 2, 2025
All-atom biomolecular structure prediction with adapters for allosteric states, user-defined interface constraints, and binding affinity.